High-Content Imaging @ SiSP
A Hub for Drug Discovery Innovation
In our pursuit of transformative solutions in drug discovery, our high-content imaging facility stands as a beacon of innovation and efficiency. Featuring state-of-the-art platforms including Operetta and Operetta CLS, our facility offers unparalleled capabilities:
Advanced Imaging Systems
Operetta: Recognized for its precision and performance, the Operetta platform delivers detailed, quantitative insights, enabling complex analyses in cellular research.
Operetta CLS: With its wide range of applications, Operetta CLS provides high-content screening, live cell imaging, and multi-dimensional capturing, all tailored to meet the diverse demands of modern drug discovery.
Automation for Enhanced Throughput
Integrated with cutting-edge automation systems, our imaging facility streamlines workflows, maximizes efficiency, and minimizes manual errors.
Scalable and customizable solutions support both high-throughput and high-content screening, expediting your research and development timelines.
Applications in Drug Discovery
Target Identification: Rapidly identify and validate novel drug targets through detailed image analysis.
Compound Screening: Automate the screening of compound libraries, evaluating the efficacy and safety of potential drug candidates.
Biomarker Discovery: Leverage our advanced imaging capabilities to discover new biomarkers, enhancing diagnostic precision and treatment personalization.
Collaborate with Us
Whether you are an academic researcher, a pharmaceutical company, or a biotech startup, our high-content imaging facility offers the tools and expertise to accelerate your drug discovery endeavors. With a commitment to quality, innovation, and collaboration, we invite you to explore how our facility can advance your projects.
Contact us today to schedule a consultation or tour of our state-of-the-art imaging facility.